Literature DB >> 11602623

Corticotropin-releasing hormone regulates IL-6 expression during inflammation.

M Venihaki1, P Dikkes, A Carrigan, K P Karalis.   

Abstract

Stimulation of the hypothalamic-pituitary-adrenal (HPA) axis by proinflammatory cytokines results in increased release of glucocorticoid that restrains further development of the inflammatory process. IL-6 has been suggested to stimulate the HPA axis during immune activation independent of the input of hypothalamic corticotropin-releasing hormone (CRH). We used the corticotropin-releasing hormone-deficient (Crh(-/-)) mouse to elucidate the effect of CRH deficiency on IL-6 expression and IL-6-induced HPA axis activation during turpentine-induced inflammation. We demonstrate that during inflammation CRH is required for a normal adrenocorticotropin hormone (ACTH) increase but not for adrenal corticosterone rise. The paradoxical increase of plasma IL-6 associated with CRH deficiency suggests that IL-6 release during inflammation is CRH-dependent. We also demonstrate that adrenal IL-6 expression is CRH-dependent, as its basal and inflammation-induced expression is blocked by CRH deficiency. Our findings suggest that during inflammation, IL-6 most likely compensates for the effects of CRH deficiency on food intake. Finally, we confirm that the HPA axis response is defective in Crh(-/-)/IL-6(-/-) mice. These findings, along with the regulation of IL-6 by CRH, support the importance of the interaction between the immune system and the HPA axis in the pathophysiology of inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602623      PMCID: PMC209527          DOI: 10.1172/JCI12869

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

Review 1.  The immune-hypothalamic-pituitary-adrenal axis.

Authors:  A Bateman; A Singh; T Kral; S Solomon
Journal:  Endocr Rev       Date:  1989-02       Impact factor: 19.871

2.  CRF antagonist partially reverses CRF- and stress-induced effects on feeding.

Authors:  D D Krahn; B A Gosnell; M Grace; A S Levine
Journal:  Brain Res Bull       Date:  1986-09       Impact factor: 4.077

Review 3.  Shared ligands and receptors as a molecular mechanism for communication between the immune and neuroendocrine systems.

Authors:  J E Blalock
Journal:  Ann N Y Acad Sci       Date:  1994-11-25       Impact factor: 5.691

4.  Expression of the rat arginine vasopressin gene in transgenic mice.

Authors:  F D Grant; J Reventos; J W Gordon; S Kawabata; M Miller; J A Majzoub
Journal:  Mol Endocrinol       Date:  1993-05

5.  Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo.

Authors:  K Karalis; H Sano; J Redwine; S Listwak; R L Wilder; G P Chrousos
Journal:  Science       Date:  1991-10-18       Impact factor: 47.728

6.  Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes.

Authors:  A Stephanou; D S Jessop; R A Knight; S L Lightman
Journal:  Brain Behav Immun       Date:  1990-03       Impact factor: 7.217

7.  The effect of interleukin-6 on pituitary hormone release in vivo and in vitro.

Authors:  K Lyson; S M McCann
Journal:  Neuroendocrinology       Date:  1991-09       Impact factor: 4.914

8.  Complement component C3-derived neutrophil chemotactic factors purified from exudate of rat carrageenin-induced inflammation.

Authors:  H Nakagawa; N Komorita
Journal:  Biochem Biophys Res Commun       Date:  1993-08-16       Impact factor: 3.575

9.  Corticotropin-releasing factor mRNA in rat thymus and spleen.

Authors:  F Aird; C V Clevenger; M B Prystowsky; E Redei
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

View more
  25 in total

1.  Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes.

Authors:  Eric M Smith; Mike Gregg; Farhad Hashemi; Liesl Schott; Thomas K Hughes
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

2.  Serum cytokines and critical illness-related corticosteroid insufficiency.

Authors:  Yong Soo Kwon; Gee Young Suh; Kyeongman Jeon; So Young Park; So Yeon Lim; Won-Jung Koh; Man Pyo Chung; Hojoong Kim; O Jung Kwon
Journal:  Intensive Care Med       Date:  2010-07-28       Impact factor: 17.440

Review 3.  What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Authors:  Jennifer Manning; Dervla O'Malley
Journal:  J Muscle Res Cell Motil       Date:  2015-02-11       Impact factor: 2.698

4.  Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response.

Authors:  Elena Gonzalez-Rey; Alejo Chorny; Nieves Varela; Gema Robledo; Mario Delgado
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 5.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

Review 6.  Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets.

Authors:  Francis J Herman; Sherry Simkovic; Giulio M Pasinetti
Journal:  Br J Pharmacol       Date:  2019-03-21       Impact factor: 8.739

7.  Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor.

Authors:  Jeffrey S Stehouwer; Matthew S Birnbaum; Ronald J Voll; Michael J Owens; Susan J Plott; Chase H Bourke; Michael A Wassef; Clinton D Kilts; Mark M Goodman
Journal:  Bioorg Med Chem       Date:  2015-06-19       Impact factor: 3.641

Review 8.  Calcineurin signaling as a target for the treatment of alcohol abuse and neuroinflammatory disorders.

Authors:  Patrick J Ronan; Sarah A Flynn; Thomas P Beresford
Journal:  Prog Mol Biol Transl Sci       Date:  2019-08-12       Impact factor: 3.622

Review 9.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.

Authors:  Marni N Silverman; Brad D Pearce; Christine A Biron; Andrew H Miller
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

Review 10.  The relationship and potential mechanistic pathways between sleep disturbances and maternal hyperglycemia.

Authors:  Bilgay Izci-Balserak; Grace W Pien
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.